The liver and spleen interventional therapy for primary carcinoma of the liver with hyperspleenism

VernacularTitle:双介入疗法治疗原发性肝癌伴脾功能亢进25例疗效观察
Author: Ruiwen CHEN ; Mingli WANG
Publication Type:Journal Article
Keywords: Liver Neoplasms; Hyperspleenism; Interventional chemotherapy
From: Chinese Journal of Primary Medicine and Pharmacy 2010;17(8):1033-1034
CountryChina
Language:Chinese
Abstract: Objective To study the value of the liver and spleen interventional therapy in primary carcinoma of the liver with hyperspleenism. Methods The treatment was given to 25 patients. Using the method of Seldinger,the 5FRH into artery hepatica propria to infuse 2/3 of the overall dose of chemotherapy medicine and embolism was inserted into the liver segment. Then 1/3 of it was infused into artery lienalis and gelatin sponge was infused into artery lienalis Rr. lienales. Combined regimens were used in chemotherapy: 5-Fu 750mg, EADM 40mg, MMC 10mmg,and 10 of the 25 added DDP 40mg. LUF and gelatin sponge were used for embolisation. Results Of the 25 patients,the WBC and PLT increased in 25 patients 4 weeks after the operation. The difference was significant. The survival rate at 6 and 12 months was 100% and 60% respectively,with 1 case of CR,8 cases of PR and 6 cases of SD. Patients had fever after the treatment but few with abnormal liver function tests. Conclusion Liver and spleen interventional therapy may relieve hyperspleenism and suggests that the treatment of primary carcinoma of the liver is effective.